Daniel brings an unusual combination of big pharma venture investing experience from LEO Pharma, corporate strategy background from Coca-Cola and McKinsey, and hands-on translational science work through Stanford's SPARK program that helps him evaluate biotech and life sciences startups from both academic and corporate perspectives. He operates structured scouting networks across the US, Europe, Canada, and Israel while actively mentoring at multiple elite programs including Alchemist Accelerator and Stanford School of Medicine, positioning him as a connector between academic research, enterprise stakeholders, and early-stage founders. Daniel brings an unusual combination of big pharma venture investing experience from LEO Pharma, corporate strategy background from Coca-Cola and McKinsey, and hands-on translational science work through Stanford's SPARK program that helps him evaluate biotech and life sciences startups from both academic and corporate perspectives. He operates structured scouting networks across the US, Europe, Canada, and Israel while actively mentoring at multiple elite programs including Alchemist Accelerator and Stanford School of Medicine, positioning him as a connector between academic research, enterprise stakeholders, and early-stage founders.